Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2007 2
2008 3
2009 2
2010 1
2016 1
2017 1
2019 1
2020 7
2021 5
2022 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia.
Metheny LL, Sobecks R, Cho C, Fu P, Margevicius S, Wang J, Ciarrone L, Kopp S, Convents RD, Majhail N, Caimi PF, Otegbeye F, Cooper BW, Gallogly M, Malek E, Tomlinson B, Gerds AT, Hamilton B, Giralt S, Perales MA, de Lima M. Metheny LL, et al. Among authors: gallogly m. Blood Adv. 2024 Mar 26;8(6):1384-1391. doi: 10.1182/bloodadvances.2023011514. Blood Adv. 2024. PMID: 38170741 Free PMC article.
Influence of gut microbiome on multiple myeloma: friend or foe?
Ahmed N, Ghannoum M, Gallogly M, de Lima M, Malek E. Ahmed N, et al. Among authors: gallogly m. J Immunother Cancer. 2020 Jun;8(1):e000576. doi: 10.1136/jitc-2020-000576. Epub 2020 Jun 23. J Immunother Cancer. 2020. PMID: 32581045 Free PMC article.
History of drug use in allogeneic hematopoietic cell transplant recipients.
Abou-Ismail MY, Ravi G, Fu P, Cao S, Vuyyala S, Caimi P, Kolk M, Ferrari N, Boughan K, Cooper B, Gallogly M, Otegbeye F, Tomlinson B, de Lima M, Metheny L. Abou-Ismail MY, et al. Among authors: gallogly m. Bone Marrow Transplant. 2021 Mar;56(3):581-585. doi: 10.1038/s41409-020-01058-z. Epub 2020 Sep 17. Bone Marrow Transplant. 2021. PMID: 32943757
Targeted Marrow Irradiation Intensification of Reduced-Intensity Fludarabine/Busulfan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation.
Ali N, Sharma AA, de Rezende ACP, Otegbeye F, Latif BM, Kerbauy MN, Cooper BW, Sanchez G, Metheny L, Bal SK, Sakuraba R, Tomlinson BK, Boughan KM, Kerbauy L, Malek E, Ribeiro AF, Gallogly M, Mansur D, Pereira G, Weltman E, Sekaly RP, de Lima M, Caimi PF, Hamerschlak N. Ali N, et al. Among authors: gallogly m. Transplant Cell Ther. 2022 Jul;28(7):370.e1-370.e10. doi: 10.1016/j.jtct.2022.04.001. Epub 2022 Apr 11. Transplant Cell Ther. 2022. PMID: 35421620 Free article. Clinical Trial.
26 results